Search alternatives:
decrease » increase (Expand Search)
Showing 81 - 100 results of 250 for search '(((( 50 ms decrease ) OR ( 50 i decrease ))) OR ((( 5 mg decrease ) OR ( 5 wt decrease ))))', query time: 0.15s Refine Results
  1. 81

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article
  2. 82

    Enhanced thermoelectric properties of Bi<sub>2</sub>Te<sub>2.55</sub>Se<sub>0.45</sub> nanocomposites using eco-friendly Eocene Midra Shale palygorskite nanofillers: A sustainable... by Farah M. El-Makaty (14157090)

    Published 2025
    “…The EMS was obtained from one of Qatar’s substantial hydrocarbon reservoirs and mixed with the Bi2Te2.55Se0.45 alloy using ball-milling and hot-pressing techniques. Different wt% of EMS (0.025, 0.05, 0.1, 0.5, and 1) were considered. …”
  3. 83
  4. 84

    Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study by Brit Mollenhauer (482499)

    Published 2018
    “…We compared four immunochemical methods for the quantification of α‐synuclein concentration in 50 unique CSF samples. All methods were designed to capture most of the existing α‐synuclein forms in CSF (‘total’ α‐synuclein). …”
  5. 85

    Exploring beyond numeric weight loss: The metabolic effects of semaglutide by Sara Sokary (17337724)

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7 %, 0.5 mg dose lowered HbA1c by 1.2–1.5 %, while the 1.0 mg dose reduced it by 1.4–1.8 %. …”
  6. 86

    Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation by Ghazi, Nicola G.

    Published 2008
    “…Six eyes underwent fluorescein angiography at the 12-week follow-up visit; 3 (50%) of these eyes had decreased leakage compared with baseline. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  7. 87

    Enhanced oil recovery using hyperbranched polyglycerol polymer-coated silica nanoparticles by Wamda Faisal Elmobarak (17058024)

    Published 2021
    “…A D<sub>PSiMNPs</sub> = 100 mg/L was sufficient to achieve %η<sub>dem</sub> of 99.4% for C<sub>oil</sub> = 100 mg/L and slightly decreased to ~93% for C<sub>oil</sub> ~4000 mg/L. …”
  8. 88

    Recovery of business intelligence systems by Haraty, Ramzi A.

    Published 2018
    “…In the worst case, the proposed algorithm takes 8.81 ms to discover the damaged part of the database; however, the fastest recent algorithm requires 50.91 ms. …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  9. 89

    In-Vitro Degradation of Hollow Silica Reinforced Magnesium Syntactic Foams in Different Simulated Body Fluids for Biomedical Applications by Manakari, Vyasaraj

    Published 2020
    “…Results indicate that corrosion resistance of the Mg-SiO₂ syntactic foam decreases with increasing chloride ion concentration of the SBF. …”
    Get full text
    article
  10. 90
  11. 91

    Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia by Haitham Elbardisi (14058048)

    Published 2021
    “…Patients with hyperprolactinemia received treatment with cabergoline 0.5 mg once per week for 6 months and were re-evaluated. …”
  12. 92

    Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines by Najlah, Mohammad

    Published 2016
    “…Clinoleic loaded with paclitaxel decreased the viability of U87-MG cell to 6.4±2.3%, compared to Intralipid loaded with paclitaxel (21.29±3.82%). …”
    Get full text
    Get full text
    Get full text
    article
  13. 93

    Interleukin-35 and Thymoquinone nanoparticle-based intervention for liver protection against paracetamol-induced liver injury in rats by Maisa Siddiq Abduh (16381125)

    Published 2023
    “…Group IV (PAR) received 600 mg/kg of PAR orally; V (PAR + IL-35) and VI (PAR + TYHO); rats received 600 mg/kg of PAR orally and i.p injection of IL-35 (200 ng/kg) or THYO (0.5 mg/kg), respectively. …”
  14. 94

    Insulin detemir in combination with oral antidiabetic drugs improves glycemic control in persons with type 2 diabetes in Near East countrie by Echtay, Akram

    Published 2017
    “…Three adverse events but no ADR or serious ADR were reported. Body weight decreased from 80.4±13.2 Kg to 79.9±12.5 Kg (P<.0001). …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  15. 95

    Synthetic Cannabinoid AB-FUBINACA Negatively Impacted the Male Fertility and Induced Testicular Toxicity by Ayman Alzu’bi (13162392)

    Published 2025
    “…AB-FUBINACA treatment also causes a significant dose related decrease in sperm viability. These findings were associated with higher level of oxidative stress (GP91 expression and malondialdehyde level) and elevated expression of key regulators of apoptosis (Bax and caspase-3) as well as reduced expression of mitochondrial respiratory chain complexes SDHB (II), UQCRC2 (III), and ATP5a (V) in the testicular tissue.…”
  16. 96

    Graphite and metal nitrate-infused HDPE composites for enhanced thermal performance in energy-efficient building envelopes by Mohammad Amir Khan (23770803)

    Published 2025
    “…In this work, the high-density polyethylene (HDPE) composites loaded with graphite and different metal (Cu, Mg, Bi, Fe, Sr, Na) nitrate doped carbon quantum dots (CQDs) are presented. …”
  17. 97

    The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children by Saade, Rami

    Published 2013
    “…For patients given Broncho-Vaxom, we defined response as a decrease in the frequency of acute tonsillitis episodes after 3 months of therapy (partial: by ≤50% and total: by >50%). …”
    Get full text
    Get full text
    Get full text
    Get full text
    article
  18. 98
  19. 99
  20. 100